Methods and systems for producing nanolipoprotein particles
US-2019094230-A1 · Mar 28, 2019 · US
US10934628B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10934628-B2 |
| Application number | US-201816167384-A |
| Country | US |
| Kind code | B2 |
| Filing date | Oct 22, 2018 |
| Priority date | Sep 22, 2014 |
| Publication date | Mar 2, 2021 |
| Grant date | Mar 2, 2021 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Methods and systems for hydrogen production or production of a reduced target molecule are described, wherein a nicotinamide co-factor dependent membrane hydrogenase or a nicotinamide co-factor dependent membrane enzyme presented on a nanolipoprotein adsorbed onto an electrically conductive supporting structure, which can preferably be chemically inert, is contacted with protons or a target molecule to be reduced and nicotinamide cofactors in presence of an electric current and one or more electrically driven redox mediators. Methods and systems for production of hydrogen or a reduced target molecule are also described wherein a membrane-bound hydrogenase enzyme or enzyme capable or reducing a target molecule is contacted with protons or the target molecule, a nicotinamide co-factor and a nicotinamide co-factor dependent membrane hydrogenase presented on a nanolipoprotein particle for a time and under condition to allow hydrogen production or production of a reduced target molecule in presence of an electrical current and of an electrically driven redox mediator.
Opening claim text (preview).
The invention claimed is: 1. A system for hydrogen production, the system comprising: nanolipoprotein particles presenting a nicotinamide co-factor dependent membrane enzyme, at least two opposing electrodes, comprising a first electrode and a second electrode opposing the first electrode, and an electrically conductive supporting structure between said first electrode and said second electrode, wherein the nanolipoprotein particles are immobilized to the electrically conductive supporting structure and wherein the nanolipoprotein particles, the at least two opposing electrodes and the electrically conductive supporting structure are in a configuration adapted to produce a product from an enzyme-mediated biological reduction reaction. 2. The system according to claim 1 , the system further comprising: a voltage generator, connected to the first and second electrodes. 3. The system according to claim 2 , wherein the voltage generator is configured to create an electric potential of 500 mV between the first and second electrodes. 4. The system according to claim 1 , further comprising an ion exchange membrane between the electrically conductive supporting structure and the second electrode. 5. The system according to claim 1 , wherein the electrically conductive supporting structure is chemically inert. 6. The system according to claim 1 , wherein the electrically conductive supporting structure is an electrically conductive porous supporting structure. 7. The system according to claim 6 , wherein the electrically conductive porous supporting structure comprises graphite beads having a diameter less than or equal to 400 μm. 8. The system according to claim 6 , wherein the electrically conductive porous supporting structure is a mesoporous structure. 9. The system according to claim 8 , wherein the mesoporous structure comprises a three-dimensional mesoporous carbon network structure. 10. The system according to claim 9 , wherein the mesoporous structure further comprises graphitic carbon material. 11. The system according to claim 8 , wherein the mesoporous structure is a graphitic carbon aerogel. 12. The system according to claim 1 , further comprising an oxygen removal system configured to remove dissolved oxygen from a buffer solution containing reagents and flowing through the system. 13. The system according to claim 12 , wherein the oxygen removal system comprises an argon gas bubbler. 14. A method comprising: combining protons, a nicotinamide co-factor and the nicotinamide co-factor dependent membrane enzyme presented on the nanolipoprotein particles immobilized on the electrically conductive supporting structure for a time and under condition to allow production of the product of the enzyme-mediated biological reduction reaction in presence of an electrical current and of an electrically driven redox mediator, the combining performed in the system of claim 1 . 15. The method of claim 14 , wherein the nicotinamide co-factor dependent membrane enzyme is one of malate dehydrogenase, succinate dehydrogenase, lactate dehydrogenase, formate dehydrogenase, L-lactate dehydrogenase, and proline dehydrogenase. 16. The method according to claim 14 , wherein the electrically driven redox mediator comprises a metallic redox mediator. 17. The method according to claim 14 , wherein the combining is performed by contacting a solution comprising the protons, the nicotinamide co-factor and the electrically driven/recycled redox mediator with the electrically conductive supporting structure in presence of the electric current. 18. The method according to claim 14 , wherein the electric current is less than 10 milliamps. 19. A system comprising: a nicotinamide co-factor dependent membrane enzyme presented on a nanolipoprotein particle; and an electrochemical flow cell comprising a first electrode and a second electrode, an electrically conductive supporting structure wherein the electrochemical flow cell is configured to receive a solution in a space between the first electrode and the second electrode, and wherein the electrically conductive supporting structure is configured to immobilize the nicotinamide co-factor dependent membrane enzyme presented on the nanolipoprotein particle and to be exposed to the solution in the electrochemical flow cell in a configuration adapted to produce a product from an enzyme-mediated biological reduction reaction. 20. The system according to claim 19 , wherein the electrochemical flow cell comprises the nanolipoprotein particles herein described immobilized on the electrically conductive supporting structure. 21. The system according to claim 19 , wherein the electrochemical flow cell further comprises an ion exchange membrane between said first and second electrodes. 22. A method comprising: providing a solution containing protons, nicotinamide co-factors and one or more electrically driven redox mediators into the electrochemical flow cell of the system of claim 19 ; and applying a voltage across the first electrode and the second electrode of the electrochemical flow cell. 23. The method according to claim 21 , further comprising capturing the product generated in the electrochemical flow cell. 24. The method according to claim 20 , further comprising removing dissolved oxygen from the solution prior to the providing the solution through the electrochemical flow cell. 25. A method comprising: contacting protons, a nicotinamide co-factor and the nicotinamide co-factor dependent membrane enzyme presented on the nanolipoprotein particle for a time and under condition to allow production of the product from the enzyme-mediated biological reduction reaction in presence of an electrical current and of an electrically driven redox mediator, the contacting performed in the system of claim 19 . 26. The method according to claim 25 , wherein the electrically driven redox mediator is a metallic electrically recycled redox mediator. 27. The method according to claim 26 , wherein the electrically recycled redox mediator is (pentamethylcyclopentadienyl-2,2′ bipyridine hydrogen) rhodium (I). 28. The method according to claim 25 , wherein the nicotinamide co-factor is nicotinamide adenine dinucleotide phosphate. 29. The method according to claim 25 , wherein the nicotinamide co-factor dependent membrane enzyme is one of malate dehydrogenase, succinate dehydrogenase, lactate dehydrogenase, formate dehydrogenase, L-lactate dehydrogenase, and proline dehydrogenase. 30. A system comprising: a nicotinamide co-factor, a nicotinamide co-factor dependent membrane enzyme presented on a nanolipoprotein particle, at least two opposing electrodes for providing an electric current, and an electrically driven redox mediator for simultaneous combined or sequential use together with the at least two opposing electrodes configured to provide electrons to the nicotinamide co-factor, wherein the nicotinamide co-factor dependent membrane enzyme is immobilized on an electrically conductive structure and wherein the nicotinamide co-factor, the nicotinamide co-factor dependent membrane enzyme and electrically driven redox mediator are in a configuration adapted to produce a product from an enzyme-mediated biological reduction reaction. 31. The system according to claim 30 , wherein the electri
Hydrogen or oxygen · CPC title
Supplying or removing reactants or electrolytes; Regeneration of electrolytes · CPC title
characterised by shape or form · CPC title
characterised by the electrocatalyst material · CPC title
Reduction · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.